help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 8, 2007
Endocrinology, doi:10.1210/en.2007-0968
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/2/741    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dov, A.
Right arrow Articles by Nesher, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dov, A.
Right arrow Articles by Nesher, R.

Submitted on July 16, 2007
Accepted on November 1, 2007

Diminished PDE8B potentiates biphasic insulin response to glucose

Avital Dov, Eva Abramovitch, Nasim Warwar, and Rafael Nesher*

Endocrinology and Metabolism Service, Department of Medicine, Hadassah, the Hebrew University Medical Center, Jerusalem, Israel

* To whom correspondence should be addressed. E-mail: rafael.nesher{at}huji.ac.il.

Cyclic AMP activates multiple signal pathways, crucial for the pancreatic {beta}-cells cell's function and survival, and is a major potentiator of insulin release. A family of PDEs terminate the cyclic AMP signals. We examined the expression of PDEs in rat {beta}-cells and their role in the regulation of insulin response. Using RT-PCR and Western blot analyses, we identified PDE3A, PDE3B, PDE4B, PDE4D and PDE8B in rat islets and in INS-1E cells, and several possible splice variants of these PDEs. Specific depletion of PDE3A with siRNA (siPDE3A) led to a small (67%) increase in the insulin response to glucose in INS-1E cells but not in rat islets. siPDE3A had no effect on the GLP-1 (10 nmol/l) potentiated insulin response in rat islets. Depletion in PDE8B levels in rat islets using similar technology (siPDE8B) increased insulin response to glucose by 70%, the potentiation being of similar magnitude during 1st and 2nd phase insulin release. The siPDE8B –potentiated insulin response was further increased by 23% when GLP-1 was included during the glucose stimulus. PDE8B is expressed in a small number of tissues unrelated to glucose or fat metabolism. We propose that PDE8B, an IBMX-insensitive cyclic AMP-specific phosphodiesterase, could prove a novel target for enhanced insulin response, affecting a specific pool of cyclic AMP involved in the control of insulin granule trafficking and exocytosis. Finally, we discuss evidence for functional compartmentation of cyclic AMP in pancreatic {beta}-cells.


Key words: insulin secretion • cyclic AMP • pancreatic {beta}-cells • phosphodiesterase isoenzymes • type 2 diabetes • drug target







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society